Dermapharm Holding SE (ETR:DMP)
Germany
· Delayed Price · Currency is EUR 38.35
+0.50 (1.32%)
Apr 25, 2025, 5:35 PM CET
Dermapharm Holding SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 113.79 | 62.37 | 134.24 | 209.58 | 85.83 | Upgrade
|
| Depreciation & Amortization | 34.93 | 33.38 | 23.7 | 20.66 | 19.17 | Upgrade
|
| Other Amortization | 43.53 | 52.57 | 27.73 | 24.59 | 24.67 | Upgrade
|
| Loss (Gain) From Sale of Assets | 2.72 | -2.57 | -0.2 | -0.4 | -0.14 | Upgrade
|
| Asset Writedown & Restructuring Costs | 8.32 | 15.82 | 43.48 | 9.91 | 3.58 | Upgrade
|
| Loss (Gain) on Equity Investments | -1.52 | 7.16 | 13.54 | -0.32 | 1.5 | Upgrade
|
| Other Operating Activities | 17.67 | 41.65 | 50.18 | 32.62 | 10.3 | Upgrade
|
| Change in Other Net Operating Assets | -18.06 | 9.04 | -4.14 | -46.27 | -13.81 | Upgrade
|
| Operating Cash Flow | 201.38 | 219.42 | 288.53 | 250.37 | 131.1 | Upgrade
|
| Operating Cash Flow Growth | -8.22% | -23.95% | 15.24% | 90.98% | 30.30% | Upgrade
|
| Capital Expenditures | -38.24 | -41.54 | -39.01 | -61.2 | -40.8 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.79 | 2.82 | 0.68 | 2.52 | 0.58 | Upgrade
|
| Cash Acquisitions | - | -389.4 | -69.79 | -22.51 | -68.83 | Upgrade
|
| Investment in Securities | 0.3 | 7.95 | 3.93 | -48.25 | - | Upgrade
|
| Other Investing Activities | 4.53 | 4.74 | 5.18 | 0.1 | 3.13 | Upgrade
|
| Investing Cash Flow | -29.61 | -415.43 | -99.01 | -129.35 | -105.91 | Upgrade
|
| Long-Term Debt Issued | 111.17 | 715 | 469.95 | 10 | 58.44 | Upgrade
|
| Long-Term Debt Repaid | -219.3 | -420.86 | -541.19 | -35.91 | -6.79 | Upgrade
|
| Net Debt Issued (Repaid) | -108.13 | 294.14 | -71.24 | -25.91 | 51.65 | Upgrade
|
| Common Dividends Paid | -47.38 | -56.53 | -116.83 | -47.38 | -43.07 | Upgrade
|
| Other Financing Activities | -53.66 | -33.07 | -11.69 | -7.69 | -22.67 | Upgrade
|
| Financing Cash Flow | -209.17 | 204.54 | -199.77 | -80.98 | -14.09 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.04 | -0 | -0.15 | 1.07 | -0.62 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | -0.83 | - | 0 | 0.83 | Upgrade
|
| Net Cash Flow | -37.44 | 7.7 | -10.4 | 41.11 | 11.31 | Upgrade
|
| Free Cash Flow | 163.14 | 177.88 | 249.52 | 189.17 | 90.3 | Upgrade
|
| Free Cash Flow Growth | -8.29% | -28.71% | 31.91% | 109.48% | 66.70% | Upgrade
|
| Free Cash Flow Margin | 13.65% | 15.46% | 23.98% | 19.70% | 11.17% | Upgrade
|
| Free Cash Flow Per Share | 3.03 | 3.30 | 4.63 | 3.51 | 1.68 | Upgrade
|
| Cash Interest Paid | 53.65 | 33.07 | 7.76 | 7.69 | 9.16 | Upgrade
|
| Cash Income Tax Paid | 83.84 | 65.37 | 40.59 | 44.85 | 38.19 | Upgrade
|
| Levered Free Cash Flow | 99.52 | 106.43 | 218.88 | 127.86 | 60.07 | Upgrade
|
| Unlevered Free Cash Flow | 136.03 | 140.78 | 226.59 | 133.38 | 65.92 | Upgrade
|
| Change in Net Working Capital | 42.99 | 24.35 | -37.47 | 35.61 | 24.71 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.